• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[14C]Aminopyrine breath analysis and conventional biochemical tests as predictors of survival in cirrhosis.

作者信息

Henry D A, Kitchingman G, Langman M J

出版信息

Dig Dis Sci. 1985 Sep;30(9):813-8. doi: 10.1007/BF01309509.

DOI:10.1007/BF01309509
PMID:3928286
Abstract

Twenty-eight patients with histologically confirmed cirrhosis were followed for up to 3.8 years after [14C]aminopyrine breath analysis. Survival rates were calculated by life-table method and outcome analyzed by log rank test. A normal breath test score was associated with a higher probability of survival than a low score, although the difference was not statistically significant. A normal serum albumin was a better predictor of outcome. Survival curves constructed according to the results of breath analysis and serum albumin differed in that the former appeared to predict early survival and the latter late survival. For this reason, data were reanalyzed by subjects' results for both tests. A normal breath test score and a normal serum albumin was associated with a significantly higher probability of survival than an abnormal result for either test.

摘要

相似文献

1
[14C]Aminopyrine breath analysis and conventional biochemical tests as predictors of survival in cirrhosis.
Dig Dis Sci. 1985 Sep;30(9):813-8. doi: 10.1007/BF01309509.
2
The relationship between aminopyrine breath test and severity of liver disease in cirrhosis.氨基比林呼气试验与肝硬化患者肝脏疾病严重程度的关系。
Am J Gastroenterol. 1981 Aug;76(2):110-3.
3
Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates.使用Child-Pugh评分和氨基比林呼气试验作为时间依存协变量,通过Cox回归模型更新肝硬化的预后。
Ital J Gastroenterol Hepatol. 1998 Jun;30(3):276-82.
4
Prognostic value of the intravenous 14C-aminopyrine breath test compared to the Child-Pugh score and serum bile acids in 84 cirrhotic patients.84例肝硬化患者中静脉注射14C-氨基比林呼气试验与Child-Pugh评分及血清胆汁酸相比的预后价值。
Digestion. 1991;50(3-4):212-8. doi: 10.1159/000200763.
5
Assessment of the (14C) aminopyrine breath test in liver disease.(14C)氨基比林呼气试验在肝脏疾病中的评估
Gut. 1978 Jan;19(1):40-5. doi: 10.1136/gut.19.1.40.
6
Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis.氨基比林呼气试验在肝硬化患者预后评估中的应用
Gut. 1992 Jun;33(6):836-42. doi: 10.1136/gut.33.6.836.
7
Aminopyrine disposition: studies on breath, saliva, and urine of normal subjects and patients with liver disease.氨基比林的处置:对正常受试者和肝病患者的呼吸、唾液及尿液的研究。
Clin Pharmacol Ther. 1976 Dec;20(6):654-60. doi: 10.1002/cpt1976206654.
8
13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.正常受试者和肝硬化患者口服13C-氨基比林后呼出气体中13CO2的排泄。与MEGX试验在慢性肝炎和肝硬化功能鉴别中的比较。
Hepatogastroenterology. 2000 Jan-Feb;47(31):234-8.
9
Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score.肝硬化患者中半乳糖清除能力、氨基比林呼气试验和吲哚菁绿清除率的预后价值。与Pugh评分的比较。
Dig Dis Sci. 1991 Sep;36(9):1197-203. doi: 10.1007/BF01307508.
10
Prognostic value of the aminopyrine breath test in cirrhotic patients.氨基比林呼吸试验在肝硬化患者中的预后价值。
Hepatology. 1986 Sep-Oct;6(5):928-31. doi: 10.1002/hep.1840060520.

引用本文的文献

1
Relationship between 13C-aminopyrine breath test and the MELD score and its long-term prognostic use in patients with cirrhosis.13C- 氨替比林呼气试验与 MELD 评分的关系及其在肝硬化患者中的长期预后应用。
Dig Dis Sci. 2013 Oct;58(10):3024-8. doi: 10.1007/s10620-013-2739-1. Epub 2013 Jul 2.
2
Use of a 13C-aminopyrine blood test: first clinical impressions.13C-氨基比林血液检测的应用:初步临床印象
Can J Vet Res. 2003 Jul;67(3):183-8.
3
Can quantitative tests of liver function discriminate between different etiologies of liver cirrhosis?

本文引用的文献

1
THE GALACTOSE ELIMINATION CAPACITY IN RELATION TO CLINICAL AND LABORATORY FINDINGS IN PATIENTS WITH CIRRHOSIS.
Acta Med Scand. 1964 Mar;175:291-300. doi: 10.1111/j.0954-6820.1964.tb00577.x.
2
Predicting outcome of paracetamol poisoning by use 14C-aminopyrine breath test.通过使用14C-氨基比林呼气试验预测对乙酰氨基酚中毒的结果。
Br Med J. 1980 Feb 2;280(6210):279-80. doi: 10.1136/bmj.280.6210.279.
3
[14C]Aminopyrine breath test in chronic liver disease: preliminary diagnostic implications.慢性肝病患者的[14C]氨基比林呼气试验:初步诊断意义
肝功能定量检测能否区分肝硬化的不同病因?
Dig Dis Sci. 2002 Dec;47(12):2669-73. doi: 10.1023/a:1021088618300.
4
Preliminary studies of a canine 13C-aminopyrine demethylation blood test.犬类13C-氨基比林去甲基化血液检测的初步研究。
Can J Vet Res. 2001 Jan;65(1):45-9.
5
Parameters of microsomal and cytosolic liver function but not of liver perfusion predict portal vein velocity in noncirrhotic patients with chronic hepatitis C.微粒体和胞质肝功能参数而非肝脏灌注参数可预测非肝硬化慢性丙型肝炎患者的门静脉血流速度。
Dig Dis Sci. 2000 Nov;45(11):2233-7. doi: 10.1023/a:1026600921967.
6
Oral or intravenous lidocaine administration to perform megx test?口服或静脉注射利多卡因以进行美蓝试验?
Dig Dis Sci. 2000 May;45(5):1011-2. doi: 10.1023/a:1005549813970.
7
Drug administration in chronic liver disease.慢性肝病中的药物给药
Drug Saf. 1997 Jul;17(1):47-73. doi: 10.2165/00002018-199717010-00004.
8
Factors influencing survival at one year in patients with nonbiliary hepatic parenchymal cirrhosis.非胆汁性肝实质肝硬化患者一年生存率的影响因素
Dig Dis Sci. 1990 Jan;35(1):1-5. doi: 10.1007/BF01537214.
9
Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score.肝硬化患者中半乳糖清除能力、氨基比林呼气试验和吲哚菁绿清除率的预后价值。与Pugh评分的比较。
Dig Dis Sci. 1991 Sep;36(9):1197-203. doi: 10.1007/BF01307508.
10
Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis.氨基比林呼气试验在肝硬化患者预后评估中的应用
Gut. 1992 Jun;33(6):836-42. doi: 10.1136/gut.33.6.836.
Dig Dis Sci. 1981 Dec;26(12):1078-83. doi: 10.1007/BF01295971.
4
The quantitative liver function as measured by the galactose elimination capacity. II. Prognostic value and changes during disease in patients with cirrhosis.通过半乳糖清除能力测定的定量肝功能。II. 肝硬化患者疾病期间的预后价值及变化
Acta Med Scand. 1982;212(5):303-8.
5
Drugs as indicators of hepatic function.
Hepatology. 1982 Jan-Feb;2(1):97-105. doi: 10.1002/hep.1840020115.
6
Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis.酒精性肝硬化患者的门静脉高压、食管静脉曲张大小与胃肠道出血风险
Gastroenterology. 1980 Dec;79(6):1139-44.
7
Breath 14CO2 after intravenous administration of [14C]aminopyrine in liver diseases.肝脏疾病患者静脉注射[14C]氨基比林后的呼气14CO2 。
Dig Dis Sci. 1982 Jan;27(1):49-56. doi: 10.1007/BF01308121.
8
The relationship between aminopyrine breath test and severity of liver disease in cirrhosis.氨基比林呼气试验与肝硬化患者肝脏疾病严重程度的关系。
Am J Gastroenterol. 1981 Aug;76(2):110-3.
9
Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism.西咪替丁和雷尼替丁:对肝脏药物代谢影响的比较。
Br Med J. 1980 Sep 20;281(6243):775-7. doi: 10.1136/bmj.281.6243.775.
10
The prognostic value of clinical and laboratory data in patients with cirrhosis.肝硬化患者临床和实验室数据的预后价值。
Scand J Gastroenterol Suppl. 1970;7:181-7.